NCT03915184 2023-12-19
Clinical Trial to Evaluate Zevor-cel (CT053) in Patients With Relapsed and/or Refractory Multiple Myeloma (LUMMICAR STUDY 2)
CARsgen Therapeutics Co., Ltd.
Phase 1/2 Active not recruiting
CARsgen Therapeutics Co., Ltd.
Celgene
Celgene
GlaxoSmithKline
SPGO Research Mannheim GmbH